Andrea Pfeifer, Co-Founder and CEO of AC Immune, examines how active immunotherapies could lead to a better treatment of Alzheimer’s disease.   Alzheimer’s disease is still, after so many decades, one of the greatest public health challenges. It affects millions of patients and their families, with an annual global cost that is above US$ 1.3 trillion and […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!